Ono Richard Dana 4
Research Summary
AI-generated summary
Lipocine (LPCN) Director Richard Ono Receives 1,764-Share Award
What Happened
Richard Ono, a director of Lipocine Inc. (LPCN), was granted 1,764 shares as a derivative award on 2026-06-03. The award is recorded at $2.19 per share for a total reported value of $3,863. This was an acquisition/award (transaction code A), not a sale.
Key Details
- Transaction date and price: 2026-06-03 at $2.19 per share (total $3,863).
- Shares acquired: 1,764 derivative shares (award).
- Vesting: Footnote F1 — 100% vests one year from the grant date (i.e., fully vesting 2027-06-03).
- Shares owned after transaction: Not specified in the provided data.
- Filing timeliness: Report filed 2026-06-04 for a 2026-06-03 transaction (filed promptly, not marked late).
- Other notes: Report lists the grant as a derivative award (commonly RSUs or similar); no 10b5-1 plan, tax withholding, or cashless-sale details provided.
Context
This was a small-value director award that vests in one year. Derivative grants align insiders with shareholder value over the vesting period but do not indicate an immediate purchase or sale of stock.